158 related articles for article (PubMed ID: 31025496)
1. A Panel of Three Biomarkers Identified by iTRAQ for the Early Diagnosis of Pancreatic Cancer.
Wu X; Zhang ZX; Chen XY; Xu YL; Yin N; Yang J; Zhu DM; Li DC; Zhou J
Proteomics Clin Appl; 2019 Sep; 13(5):e1800195. PubMed ID: 31025496
[TBL] [Abstract][Full Text] [Related]
2. RNA-Binding Motif Protein 6 is a Candidate Serum Biomarker for Pancreatic Cancer.
Duan B; Hu X; Fan M; Xiong X; Han L; Wang Z; Tong D; Liu L; Wang X; Li W; Yang J; Huang C
Proteomics Clin Appl; 2019 Sep; 13(5):e1900048. PubMed ID: 31207145
[TBL] [Abstract][Full Text] [Related]
3. A new panel of pancreatic cancer biomarkers discovered using a mass spectrometry-based pipeline.
Liu X; Zheng W; Wang W; Shen H; Liu L; Lou W; Wang X; Yang P
Br J Cancer; 2017 Dec; 117(12):1846-1854. PubMed ID: 29123261
[TBL] [Abstract][Full Text] [Related]
4. Large-scale clinical validation of biomarkers for pancreatic cancer using a mass spectrometry-based proteomics approach.
Park J; Lee E; Park KJ; Park HD; Kim JW; Woo HI; Lee KH; Lee KT; Lee JK; Park JO; Park YS; Heo JS; Choi SH; Choi DW; Jang KT; Lee SY
Oncotarget; 2017 Jun; 8(26):42761-42771. PubMed ID: 28514751
[TBL] [Abstract][Full Text] [Related]
5. Metabolic system alterations in pancreatic cancer patient serum: potential for early detection.
Ritchie SA; Akita H; Takemasa I; Eguchi H; Pastural E; Nagano H; Monden M; Doki Y; Mori M; Jin W; Sajobi TT; Jayasinghe D; Chitou B; Yamazaki Y; White T; Goodenowe DB
BMC Cancer; 2013 Sep; 13():416. PubMed ID: 24024929
[TBL] [Abstract][Full Text] [Related]
6. A Combination of MUC5AC and CA19-9 Improves the Diagnosis of Pancreatic Cancer: A Multicenter Study.
Kaur S; Smith LM; Patel A; Menning M; Watley DC; Malik SS; Krishn SR; Mallya K; Aithal A; Sasson AR; Johansson SL; Jain M; Singh S; Guha S; Are C; Raimondo M; Hollingsworth MA; Brand RE; Batra SK
Am J Gastroenterol; 2017 Jan; 112(1):172-183. PubMed ID: 27845339
[TBL] [Abstract][Full Text] [Related]
7. Identification of highly sensitive biomarkers that can aid the early detection of pancreatic cancer using GC/MS/MS-based targeted metabolomics.
Hirata Y; Kobayashi T; Nishiumi S; Yamanaka K; Nakagawa T; Fujigaki S; Iemoto T; Kobayashi M; Okusaka T; Nakamori S; Shimahara M; Ueno T; Tsuchida A; Sata N; Ioka T; Yasunami Y; Kosuge T; Kaneda T; Kato T; Yagihara K; Fujita S; Yamada T; Honda K; Azuma T; Yoshida M
Clin Chim Acta; 2017 May; 468():98-104. PubMed ID: 28215548
[TBL] [Abstract][Full Text] [Related]
8. Identification of a novel serum biomarker for pancreatic cancer, C4b-binding protein α-chain (C4BPA) by quantitative proteomic analysis using tandem mass tags.
Sogawa K; Takano S; Iida F; Satoh M; Tsuchida S; Kawashima Y; Yoshitomi H; Sanda A; Kodera Y; Takizawa H; Mikata R; Ohtsuka M; Shimizu H; Miyazaki M; Yokosuka O; Nomura F
Br J Cancer; 2016 Oct; 115(8):949-956. PubMed ID: 27657339
[TBL] [Abstract][Full Text] [Related]
9. LC-MS/MS and SWATH based serum metabolomics enables biomarker discovery in pancreatic cancer.
Xiong Y; Shi C; Zhong F; Liu X; Yang P
Clin Chim Acta; 2020 Jul; 506():214-221. PubMed ID: 32243985
[TBL] [Abstract][Full Text] [Related]
10. Metabolomics identifies serum and exosomes metabolite markers of pancreatic cancer.
Tao L; Zhou J; Yuan C; Zhang L; Li D; Si D; Xiu D; Zhong L
Metabolomics; 2019 May; 15(6):86. PubMed ID: 31147790
[TBL] [Abstract][Full Text] [Related]
11. A Comprehensive Proteome Analysis of Peripheral Blood Mononuclear Cells (PBMCs) to Identify Candidate Biomarkers of Pancreatic Cancer.
Li H; Mao Y; Xiong Y; Zhao HH; Shen F; Gao X; Yang P; Liu X; Fu D
Cancer Genomics Proteomics; 2019; 16(1):81-89. PubMed ID: 30587502
[TBL] [Abstract][Full Text] [Related]
12. Serum peptide signatures for pancreatic cancer based on mass spectrometry: a comparison to CA19-9 levels and routine imaging techniques.
Velstra B; Vonk MA; Bonsing BA; Mertens BJ; Nicolardi S; Huijbers A; Vasen H; Deelder AM; Mesker WE; van der Burgt YE; Tollenaar RA
J Cancer Res Clin Oncol; 2015 Mar; 141(3):531-41. PubMed ID: 25240825
[TBL] [Abstract][Full Text] [Related]
13. Discovery and Validation of Biomarkers That Distinguish Mucinous and Nonmucinous Pancreatic Cysts.
Park J; Yun HS; Lee KH; Lee KT; Lee JK; Lee SY
Cancer Res; 2015 Aug; 75(16):3227-35. PubMed ID: 26122842
[TBL] [Abstract][Full Text] [Related]
14. Possible proteomic biomarkers for the detection of pancreatic cancer in oral fluids.
Deutsch O; Haviv Y; Krief G; Keshet N; Westreich R; Stemmer SM; Zaks B; Navat SP; Yanko R; Lahav O; Aframian DJ; Palmon A
Sci Rep; 2020 Dec; 10(1):21995. PubMed ID: 33319845
[TBL] [Abstract][Full Text] [Related]
15. Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma.
Cheng Y; Wang K; Geng L; Sun J; Xu W; Liu D; Gong S; Zhu Y
EBioMedicine; 2019 Feb; 40():382-393. PubMed ID: 30639415
[TBL] [Abstract][Full Text] [Related]
16. Screening for serological biomarkers of pancreatic cancer by two-dimensional electrophoresis and liquid chromatography-tandem mass spectrometry.
Wang Y; Kuramitsu Y; Yoshino S; Takashima M; Zhang X; Ueno T; Suzuki N; Oka M; Nakamura K
Oncol Rep; 2011 Jul; 26(1):287-92. PubMed ID: 21519797
[TBL] [Abstract][Full Text] [Related]
17. Identification of pancreatic juice proteins as biomarkers of pancreatic cancer.
Gao J; Zhu F; Lv S; Li Z; Ling Z; Gong Y; Jie C; Ma L
Oncol Rep; 2010 Jun; 23(6):1683-92. PubMed ID: 20428826
[TBL] [Abstract][Full Text] [Related]
18. Mass spectrometry-based iTRAQ analysis of serum markers in patients with pancreatic cancer.
Jia K; Zhao X; Dang X
Oncol Lett; 2020 Jun; 19(6):4106-4114. PubMed ID: 32382349
[TBL] [Abstract][Full Text] [Related]
19. Analytically validated protein biomarkers of chronic pancreatitis and pancreatic cancer for potential clinical diagnosis with mass spectrometry.
Chou CY; Chang CT; Chen CJ
Rapid Commun Mass Spectrom; 2020 Apr; 34 Suppl 1():e8580. PubMed ID: 31502717
[TBL] [Abstract][Full Text] [Related]
20. Plasma-Derived Exosomal ALIX as a Novel Biomarker for Diagnosis and Classification of Pancreatic Cancer.
Yang J; Zhang Y; Gao X; Yuan Y; Zhao J; Zhou S; Wang H; Wang L; Xu G; Li X; Wang P; Zou X; Zhu D; Lv Y; Zhang S
Front Oncol; 2021; 11():628346. PubMed ID: 34026608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
